Last reviewed · How we verify
NCT07205991: ADHERE
ADHERE Trial: Strategies to Improve Mobile App Adherence
NA trial testing Phone calls in Low Back Pain in 258 participants. Currently enrolling.
26 May 2027
Quick facts
| Lead sponsor | Neuroscience Research Australia |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 258 |
| Start date | 30 October 2025 |
| Primary completion | 26 May 2027 |
| Estimated completion | 26 May 2028 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Phone calls
- Text messages
- App notifications
Conditions studied
- Low Back Pain — all drugs for Low Back Pain →
Sponsor
Neuroscience Research Australia
Who can join
18 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effectiveness of two communication interventions, compared to standard app notifications, in increasing adherence to a mobile health app among individuals with chronic low back pain. The main question it aims to answer is: Do phone calls or text messages increase adherence compared to app notifications in patients receiving a digital health intervention for chronic back pain? Participants will: A) Receive pain education and clinical hypnosis via a mobile app for managing chronic LBP; B) Will be contacted up to twice via phone call or text message, or they will only receive standard notifications from the app.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07205991
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Phone calls
Trials testing the same drug.
- NCT05770570 — Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity) · Phase 2 · recruiting
- NCT03050294 — Evaluating Treatment Resistant Dermatitis TaroIIR · Phase 4 · completed
Other recruiting trials for Low Back Pain
Currently open trials in the same condition.
- NCT07526012 — Comparative Effects Of Post Isometric Relaxation Versus Active Isolated Stretch In Patients With Piriformis Syndrome · NA · recruiting
- NCT07535047 — Placebo-Induced Hypoalgesia During Transcutaneous Electrical Nerve Stimulation Application in Low Back Pain · NA · recruiting
- NCT07463729 — Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome · NA · recruiting
- NCT07250568 — Office Program Effects on Pain, Posture, Muscle Physiology, Stress, Ergonomics, and Quality of Life in LBP Workers · NA · recruiting
- NCT07467070 — Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific · NA · recruiting
Other Neuroscience Research Australia trials
Trials by the same sponsor.
- NCT06620133 — Pain Education and Patient-led Goal Setting in Adults With Chronic Low Back Pain: a Randomised Controlled Trial · NA · recruiting
- NCT06984354 — Digitally Delivered Treatments to Reduce Chronic Low Back Pain · NA · recruiting
- NCT06605248 — NOTUS Feasibility Study: Reducing Chronic Low Back Pain With Mobile App Intervention · NA · completed
- NCT06535646 — Digital Health Technology for People With Mitochondrial Disease · NA · recruiting
- NCT06504433 — The Natural History of Mitochondrial Diseases · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07205991 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neuroscience Research Australia
- Last refreshed: 14 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07205991.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing